Thailand’s stock and securities authorities are preparing to investigate irregular trading transactions by the head of Thonburi Healthcare Group (THG), Dr Boon Vanasin, prior to an announcement by the hospital it would make a major purchase of mRNA Covid-19 vaccines.
THG clarified to the Stock Exchange of Thailand (SET) the company would sign a contract to buy 20 million doses of Pfizer-BioNTech vaccines yesterday and is in the process of filing related documents to overseas dealers.
According to the Securities and Exchange Commission’s (SEC) securities and derivatives holding reports (Form 59), required when executives trade their own shares, Jaruwan Vanasin, Dr Boon’s spouse, reportedly purchased 950,000 THG shares in eight separate transactions during…
